Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139–148

Detalles Bibliográficos
Autores principales: Mita, Tomoya, Katakami, Naoto, Yoshii, Hidenori, Onuma, Tomio, Kaneto, Hideaki, Osonoi, Takeshi, Shiraiwa, Toshihiko, Kosugi, Keisuke, Umayahara, Yutaka, Yamamoto, Tsunehiko, Yokoyama, Hiroki, Kuribayashi, Nobuichi, Jinnouchi, Hideaki, Gosho, Masahiko, Shimomura, Iichiro, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439413/
https://www.ncbi.nlm.nih.gov/pubmed/28420699
http://dx.doi.org/10.2337/dc17-er06b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439413/
https://www.ncbi.nlm.nih.gov/pubmed/28420699
http://dx.doi.org/10.2337/dc17-er06b

Ejemplares similares